Symbols

HCAT

Health Catalyst·NASDAQ

--(--)

HCAT fundamentals

HCAT Q4 2025 Earnings

Health Catalyst (HCAT) released its earnings on Mar 12, 2026: revenue was 74.68M (YoY -6.19%), beat estimates; EPS was 0.08 (YoY +100.00%), missed estimates.

Revenue / YoY

74.68M

-6.19%

EPS / YoY

0.08

+100.00%

Report date

Mar 12, 2026

HCAT Earnings Call Summary for Q4,2025

New CEO Vision: Ben Albert prioritizes operational simplification, capital reallocation, & AI investment to drive long-term growth.
Mixed Financials: 2025 revenue growth (+1%) driven by tech (+7%), offset by pro services decline (-8%); EBITDA surges 59% to $41.4M.
Migration Headwinds: Q1 2026 guidance reflects $3.5M sequential decline due to $12.5M ARR downsell & $35M data platform renegotiation.
Key Metrics:
- 93% tech ARR retention
- 32 net new logos vs. 30 target
- $300-700K ARR per new logo
Growth Catalysts: Cost management solutions (e.g., Power Labor) & clinical quality apps show strong demand; AI investments position for future differentiation.

Earnings

EPS

Revenue

Revenue & Expenses

HCAT has released its 2025 Q4 earnings report, with revenue of 74.68M, reflecting a YoY change of -6.19%, and net profit of -91.03M, showing a YoY change of -340.31%. The Sankey diagram below clearly presents HCAT's revenue sources and cost distribution.

Key Indicators

Health Catalyst (HCAT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Health Catalyst (HCAT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Health Catalyst (HCAT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Health Catalyst (HCAT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown